Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes. It offers a range of evidence-based options for the design of testing interventions for different settings and populations and supports the concepts of diversifying and integrating testing services.
Reaching and testing those at risk of infection with human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a public health challenge across Europe. One in two people currently living with HIV is diagnosed late in the course of their infection and an even larger proportion of the estimated 9 million Europeans living with chronic hepatitis B or C are not aware that they are infected.
In order to interrupt existing transmission chains and prevent further infections, Europe needs a stronger focus on working closer with vulnerable populations to help better detect those with undiagnosed infections, then link them to appropriate health care services. Increasing testing coverage and uptake, especially for those most at-risk, is an essential element of any strategy to eliminate HBV, HCV and HIV in the European Union and European Economic Area (EU/EEA). To support Member States in their efforts to improve case detection and uptake of testing programmes as part of the global effort to eliminate viral hepatitis and HIV as public health threats by 2030, ECDC is providing this evidence-based guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV.
Read the guidance in brief
Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Hepatitis B and C testing activities, needs, and priorities in the EU/EEA
30 May 2017 - ECDC undertook a survey to assess needs and priorities prior to developing guidance on testing and screening for hepatitis B and C (HBV/HCV) in the EU/EEA, and to update the existing evidence on the burden of HBV/HCV morbidity and mortality across EU/EEA Member States.
The benefits of HIV treatment: undetectable means you do not pass on the virus
25 Jul 2018 - Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Public health guidance on prevention and control of blood-borne viruses in prison settings
23 Jul 2018 - This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
HIV and men who have sex with men - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
Effective use of digital platforms for STI/HIV prevention among MSM in the EU/EEA
This ECDC series provides comprehensive guides to the effective use of digital platforms for STI/HIV prevention among MSM in the EU/EEA. The guides incorporate the expertise of stakeholders, scientific literature relating to social media and digital platforms, commercial sector best practice and engagement with the platform companies themselves.Read more
Public health guidance on HIV and STI prevention among men who have sex with men
17 Jun 2015 - This guidance, based on a systematic review of the literature and expert opinion, suggests that there is good evidence to ensure that some key components are considered for inclusion in national and sub-national public health programmes in countries in Europe.
Public health guidance on active case finding of communicable diseases in prison settings
23 May 2018 - This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.